Home › Funds › Papp Small & Mid-Cap Growth Fund
Fund family: Papp Investment Trust · Filed by Papp Investment Trust (CIK 1477597) · SEC series S000027941
Ticker: PAPPX (C000084913)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 111 with, 1 against, 0 abstentions (not counted as with management). Shareholder proposals: 0 FOR, 1 AGAINST, 0 abstained, by the filing’s own vote-source field.
No item-level comparison with other Papp Investment Trust funds is possible: fewer than three other funds of the family voted in 2025-2026.
The same votes as “with management” above, by the sector of the company voted on. 100.0% of this fund’s 112 such votes could be given a sector.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Technology | 39 | 1 | 2.6% |
| Health Care | 27 | 0 | 0.0% |
| Industrials | 18 | 0 | 0.0% |
| Finance | 15 | 0 | 0.0% |
| Consumer Discretionary | 13 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 82 | 0 |
| Audit-related | 11 | 0 |
| Say-on-Pay | 10 | 0 |
| Compensation | 5 | 0 |
| Capital Structure | 2 | 0 |
| Corporate Governance | 2 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| RBC BEARINGS INCORPORATED | September 4, 2025 | $4M | 6 | 0 |
| FACTSET RESEARCH SYSTEMS INC. | December 18, 2025 | $2M | 15 | 0 |
| SILICON LABORATORIES INC. | April 23, 2026 | $2M | 5 | 0 |
| RESMED INC. | November 19, 2025 | $1M | 15 | 0 |
| T. ROWE PRICE GROUP, INC. | May 7, 2026 | $1M | 15 | 0 |
| SYNOPSYS, INC. | April 16, 2026 | $1M | 14 | 1 |
| VALVOLINE INC. | January 28, 2026 | $813,675 | 12 | 0 |
| BIO-TECHNE CORP | October 30, 2025 | $604,157 | 12 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| April 16, 2026 | SYNOPSYS, INC. | To vote on a stockholder proposal regarding 'stockholders' right to act by written consent, if properly presented at the meeting. Shareholder proposal | Against | For |
112 ballot items at 10 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Papp Small & Mid-Cap Growth Fund (PAPPX) voted at 10 shareholder meetings of 10 companies, on 112 ballot items in all. Where management made a recommendation, the fund followed it on 99.1% of the items and voted against it 1 time. Its most frequent area of disagreement was corporate governance (1 of its votes against management). It voted on 1 shareholder proposal.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.